-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2024.
- NEUROONE MEDICAL TECHNOLOGIES Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.82M, a 11% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$11.9M, a 0.57% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Operating Income (Loss) for 2024 was -$11.9M, a 0.57% increase from 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Operating Income (Loss) for 2023 was -$12M, a 19.2% decline from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Operating Income (Loss) for 2022 was -$10M, a 1.83% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)